RxDoctor Payments Data

Terrence Fullum, MD

Surgery · Washington, DCNPI 1497861942

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $29,061 of the $45,684 with a category attached, or 63.6%. Medical Device Business Services, Inc. accounts for 80.6% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $26,055 and has fallen 96.9% since, to $811 in 2025. Among surgery clinicians in DC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,684in general payments, 2019–2025

Across 138 payments — averaging $331.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$37K
  • Intuitive Surgical$6K
  • Johnson & Johnson$1K
  • Integra Lifesciences Corporation$508
  • Davol Inc.$344
  • Smith+Nephew$181
  • plus $855 from 15 others

What the payments were for

  • Consulting fees$29,06164%
  • Travel & lodging$7,55017%
  • Food & beverage$4,65010%
  • Education$4,0289%
  • Other$3951%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,684 in reported general payments places this provider in the 90th percentile of 117 surgery providers in District of Columbia.

See all surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$7,663
Medicare patients
18
Services billed
48

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole16$232

Paid to pharmacies, not to this prescriber.

Other surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →